Brain chips are no longer science fiction. They have become a reality and are transforming lives thanks to technological advancements, which allow a computer to decode brain signals, deduce human intentions, and finally enact them directly through a machine.

These systems that are making it possible are called BCI or a brain-computer interface, which studies signals from brain activity. Neuralink is the most well-known company in this field, creating a generalized brain interface to unlock human potential.

But while BCIs have been in development since the 1960s, recent advancements in AI are helping achieve miracles. These advancements have led to significant strides in practical applications, particularly for people with disabilities, showcasing the evolving impact of this technology.

Three forces will shape the business of generative AI.

Will AI now move faster and be less controlled?

It seems that the chaotic events of the last week at OpenAI have sped everything up, according to most observers.

Those warning about the risks of AI lost the battle on the drama over the control of 90 billion’s start-up OpenAI as two of the three external board members were replaced, and the outed CEO Sam Altman was reinstated.

AI agents are what they ingest. Rather than scraping the internet, it would be better to confine their diets to books and encyclopedias, says Sorin Adam Matei.

Longevity drugs for our canine companions are moving closer to reality. They also raise questions about what it might mean to succeed.

The brain-computer interface (BCI) space continues to rise in notoriety, and a number of players are throwing their hats in the ring.

Such technologies could enable users to control a computer with their brain, or even go beyond that. Countless immobile people someday could control a mouse cursor, keyboard, mobile device/tablet, wheelchair or prosthetic device by only thinking.

Big names have already established their presence in the space. Elon Musk’s Neuralink continues to make headway, while Bill Gates-and Jeff Bezos-backed Synchron has an innovative catheter-delivered implant. Blackrock Neurotech, which has a next-generation BCI, has been implanting its Utah Array in patients since 2004.

At e4m TechManch, WPP’s Daniel Hulme spoke about AI’s impact on humanity, the concept of singularity and more

By exchange4media Staff.

In a pivotal moment for the autonomous transportation industry, California chose to expand one of the biggest test cases for the technology.

The crushing demand for AI has also revealed the limits of the global supply chain for powerful chips used to develop and field AI models.

The continuing chip crunch has affected businesses large and small, including some of the AI industry’s leading platforms and may not meaningfully improve for at least a year or more, according to industry analysts.

The latest sign of a potentially extended shortage in AI chips came in Microsoft’s annual report recently. The report identifies, for the first time, the availability of graphics processing units (GPUs) as a possible risk factor for investors.

Two days after AIM said that it’s time for OpenAI to launch GPT-5, the company filed a trademark application for “GPT-5” with the United States Patent and Trademark Office (USPTO) on July 18. This move suggests the potential development of a new version of their language model. The news was shared by trademark attorney Josh Gerben on Twitter on July 31.

The trademark application says that GPT-5 is related to computer software for generating human speech and text, as well as for natural language processing, generation, understanding, and analysis. It is speculated to be the next powerful version of OpenAI’s generative chatbot, following the previous release of GPT-4 in March.

Despite the trademark application, there is no confirmation of immediate development for GPT-5. While it is likely that OpenAI has plans for an advanced language model in the future, the primary purpose of the trademark filing might be to secure the name “GPT-5” and prevent unauthorised use by others.